High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

por Qiao, G-B, Wu, Y-L, Yang, X-N, Zhong, W-Z, Xie, D, Guan, X-Y, Fischer, D, Kolberg, H-C, Kruger, S, Stuerzbecher, H-W
Publicado 2005

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers

por Skowron, K. B., Pitroda, S. P., Namm, J. P., Balogun, O., Beckett, M. A., Zenner, M. L., Fayanju, O., Huang, X., Fernandez, C., Zheng, W., Qiao, G., Chin, R., Kron, S. J., Khodarev, N. N., Posner, M. C., Steinberg, G. D., Weichselbaum, R. R.
Publicado 2016